These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28455314)

  • 1. Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    J Am Soc Nephrol; 2017 Sep; 28(9):2802-2811. PubMed ID: 28455314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Diabetologia; 2016 Feb; 59(2):244-54. PubMed ID: 26399403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention.
    Hermida RC; Crespo JJ; Otero A; Domínguez-Sardiña M; Moyá A; Ríos MT; Castiñeira MC; Callejas PA; Pousa L; Sineiro E; Salgado JL; Durán C; Sánchez JJ; Fernández JR; Mojón A; Ayala DE;
    Eur Heart J; 2018 Dec; 39(47):4159-4171. PubMed ID: 30107515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):55-67. PubMed ID: 23077972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    J Am Coll Cardiol; 2011 Sep; 58(11):1165-73. PubMed ID: 21884956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Hypertens Res; 2018 May; 41(5):342-353. PubMed ID: 29531290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Chayán L; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):221-32. PubMed ID: 23098170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy.
    Hermida RC; Smolensky MH; Ayala DE; Fernández JR; Moyá A; Crespo JJ; Mojón A; Ríos MT; Fabbian F; Portaluppi F
    Nephrol Dial Transplant; 2014 Jun; 29(6):1160-7. PubMed ID: 24009285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.